Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cost-effectiveness of early intervention in psychosis in low- and middle-income countries: economic evaluation from São Paulo, Brazil.

Epidemiology and psychiatric sciences·2024
Same author

[Incidence and case fatality rates of cardiovascular diseases in urban and rural community-dwelling populations in eastern, central and western regions of China].

Zhonghua xin xue guan bing za zhi·2024
Same author

[Clinicopathological analysis of gonadal differentiation of sex development disorder].

Zhonghua bing li xue za zhi = Chinese journal of pathology·2024
Same author

[<i>Qingshen</i> Granules-medicated serum reduces transdifferentiation of NRK-52E cells by miR-23b-5p-mediated activation of the Nrf2 pathway].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University·2024
Same author

Creating new littoral zones in a shallow lake to forward-restore an aquatic food web.

The Science of the total environment·2023
Same author

Costing analysis to introduce a contrast-enhanced mammography service to replace an existing breast MRI service for local staging of breast cancer.

Clinical radiology·2023

Related Experiment Video

Updated: Jun 2, 2026

Inhibitory Synapse Formation in a Co-culture Model Incorporating GABAergic Medium Spiny Neurons and HEK293 Cells Stably Expressing GABAA Receptors
07:51

Inhibitory Synapse Formation in a Co-culture Model Incorporating GABAergic Medium Spiny Neurons and HEK293 Cells Stably Expressing GABAA Receptors

Published on: November 14, 2014

Selective changes in single cell GABA(A) receptor subunit expression and function in temporal lobe epilepsy

A R Brooks-Kayal1, M D Shumate, H Jin

  • 1Joseph Stokes Research Institute of The Children's Hospital of Philadelphia, Department of Neurology, University of Pennsylvania, 19104, USA. kayal@email.chop.edu

Nature Medicine
|October 15, 1998
PubMed
Summary

Altered GABA(A) receptor subunit mRNA expression in the hippocampus precedes temporal lobe epilepsy onset in rats. These molecular changes are linked to receptor dysfunction, playing a key role in epileptogenesis.

More Related Videos

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

Related Experiment Videos

Last Updated: Jun 2, 2026

Inhibitory Synapse Formation in a Co-culture Model Incorporating GABAergic Medium Spiny Neurons and HEK293 Cells Stably Expressing GABAA Receptors
07:51

Inhibitory Synapse Formation in a Co-culture Model Incorporating GABAergic Medium Spiny Neurons and HEK293 Cells Stably Expressing GABAA Receptors

Published on: November 14, 2014

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Epilepsy Research

Background:

  • Temporal lobe epilepsy (TLE) is the most common seizure disorder in adults.
  • Hippocampal hyperexcitability, driven by impaired inhibitory neurotransmission, underlies TLE.
  • The precise molecular mechanisms driving this hyperexcitability remain largely unknown.

Purpose of the Study:

  • To investigate the molecular mechanisms of epileptogenesis in the hippocampus.
  • To examine changes in GABA(A) receptor subunit mRNA expression in neurons from epileptic rats.
  • To correlate gene expression alterations with changes in receptor function and epilepsy development.

Main Methods:

  • Utilized patch-clamp electrophysiology to record from single dentate granule cells.
  • Employed single-cell mRNA amplification (aRNA) to analyze gene expression.
  • Studied neurons from rats modeling temporal lobe epilepsy.

Main Results:

  • Demonstrated substantial alterations in GABA(A) receptor subunit mRNA expression in dentate granule cells of epileptic rats.
  • Observed that these gene expression changes occur weeks before epilepsy onset.
  • Found a correlation between altered gene expression and significant changes in GABA(A) receptor function.

Conclusions:

  • Aberrant expression of GABA(A) receptor subunits is a key molecular event in epileptogenesis.
  • Changes in GABA(A) receptor function contribute significantly to the hyperexcitability seen in temporal lobe epilepsy.
  • These findings provide insights into the molecular basis of epilepsy development and potential therapeutic targets.